The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis

Kristiana Salmon, Matthew C. Kiernan, Seung H. Kim, Peter M. Andersen, Adriano Chio, Leonard H. van den Berg, Philip Van Damme, Ammar Al-Chalabi, Patricia Lillo, Jinsy A. Andrews, Angela Genge

Research output: Contribution to journalComment/debatepeer-review

31 Citations (Scopus)

Abstract

Teaser Several genetically-targeted therapies are being developed for ALS. Research is increasingly supportive of a greater incidence of clinically actionable variants in sporadic ALS than previously reported. Salmon et al. outline the need to improve access, and offer genetic testing to all people diagnosed with ALS.
Original languageEnglish
Pages (from-to)1207-1210
Number of pages4
JournalBrain
Volume145
Issue number4
Early online date10 Jan 2022
DOIs
Publication statusPublished - 1 Apr 2022

Keywords

  • Neurology (clinical)

Cite this